Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis Be Coordinated with Behavioural Therapy for Dementia? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Behavioural therapy is a core part of person-centred dementia care, helping people manage anxiety, agitation, or sleep changes through structured, non-drug approaches. As medical cannabis gains attention, some families and clinicians are asking whether it can be combined with behavioural therapy to support comfort and wellbeing. The evidence so far suggests cautious potential, but integration must always occur under medical supervision. 

Can medical cannabis be accessed legally for women’s health?

Understanding Behavioural Therapy in Dementia 

Behavioural and psychological support strategies aim to identify triggers behind distress and modify responses through reassurance, routine, and environmental adjustments. They help reduce the need for sedatives or antipsychotics and are central to NICE dementia guidance (NICE, 2023). 

In recent years, researchers have explored whether medical cannabis, particularly CBD-dominant products, might help calm anxiety or improve rest when used alongside therapy. This idea aligns with the broader goal of supporting comfort without over-sedation. 

What The Evidence Says 

A 2024 review in Age and Ageing reported that CBD-based oils may modestly improve anxiety and sleep in older adults, especially when used in structured care programmes that also include behavioural or cognitive support (Age and Ageing, 2024). 

Similarly, a 2025 PubMed Central study found that low-frequency, medically supervised cannabis use did not worsen cognition or daily functioning in adults aged 65 and over (PubMed Central, 2025). Researchers suggested that cannabinoids could potentially enhance relaxation when paired with non-drug therapies, provided dosing remains conservative. 

However, both the NHS and Alzheimer’s Society caution that cannabis is not an approved treatment for dementia and must never replace behavioural interventions. Unsupervised THC use can cause confusion or fatigue, which may reduce participation in therapy sessions. 

Clinical Integration in Practice 

If a specialist clinician prescribes a cannabis-based product for symptom management, coordination with behavioural therapy should follow structured review: 

  • Therapy goals and medication aims should be defined together. 
  • Communication between clinicians and therapists ensures balanced care. 
  • Carers can help track mood, sleep, and alertness to adjust treatment safely. 
  • Any side effects should prompt reassessment by the prescribing specialist. 

Educational Context: AlleviMed 

AlleviMed provides educational information about how regulated cannabis use aligns with UK clinical frameworks. It helps explain how medical professionals monitor dosing, response, and psychological outcomes, particularly when cannabis is used alongside behavioural therapies. Dementia remains a non-licensed indication, but education supports safe, informed care coordination. 

Takeaway 

Cannabis may have a role in supporting relaxation or sleep when paired with behavioural therapy, but only under strict clinical supervision. Evidence is early, and therapy remains the cornerstone of dementia care. The most effective approach combines personalised behavioural support with careful, medically guided symptom management. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories